| Literature DB >> 25981497 |
Michelle C Stanton1, Square Z Mkwanda2, Alexander Y Debrah3, Linda Batsa4, Nana-Kwadwo Biritwum5, Achim Hoerauf6, Matthew Cliffe7, Abigail Best8, Andrew Molineux9, Louise A Kelly-Hope10.
Abstract
BACKGROUND: Lymphoedema and hydrocoele are the two most common clinical manifestations of lymphatic filariasis (LF). In order to effectively target morbidity management strategies, more information is rapidly needed on morbidity burden across all endemic countries. The purpose of this study was to develop and test an SMS tool (MeasureSMS) which enables trained community-based health workers to report basic information on all cases they identified.Entities:
Mesh:
Year: 2015 PMID: 25981497 PMCID: PMC4455607 DOI: 10.1186/s12879-015-0946-4
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Lymphoedema severity staging used in the LF morbidity case identification study. Adapted from [27]
Fig. 2Sequence diagram MeasureSMS tool. The health worker sends their SMS record in the prescribed format to a local Android Smartphone on which the MeasureSMS app is installed. The app validates the SMS i.e. checks for formatting errors and sends a response SMS to the health worker indicating whether or not the SMS was correctly formatted. On connecting to the internet either via WiFi or the local 3G network, the smartphone sends the SMS message data to a UK-based cloud server on which it is then stored. The study team, including the members of the LF Programme can then access this stored data via a password protected web browser
Age and education level summaries of HSAs (Malawi) and CHWs (Ghana) trained to undertake the LF morbidity reporting exercise
| Malawi | Ghana | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Female | Total | Males | Female | Total | |||||||
| Age group | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) |
| 18-25 | 0 | (0 %) | 0 | (0 %) | 0 | (0 %) | 1 | (4 %) | 2 | (40 %) | 3 | (9 %) |
| 26-35 | 23 | (68 %) | 18 | (69 %) | 41 | (68 %) | 3 | (11 %) | 0 | (0 %) | 3 | (9 %) |
| 36-45 | 8 | (24 %) | 7 | (27 %) | 15 | (25 %) | 8 | (30 %) | 1 | (20 %) | 9 | (28 %) |
| 46-55 | 2 | (6 %) | 1 | (4 %) | 3 | (5 %) | 5 | (19 %) | 1 | (20 %) | 6 | (19 %) |
| >55 | 0 | (0 %) | 0 | (0 %) | 0 | (0 %) | 10 | (37 %) | 1 | (20 %) | 11 | (34 %) |
| Missing | 1 | (3 %) | 0 | (0 %) | 1 | (2 %) | 0 | (0 %) | 0 | (0 %) | 0 | (0 %) |
|
| ||||||||||||
| Completed Primary | 0 | (0 %) | 2 | (8 %) | 2 | (3 %) | 6 | (22 %) | 2 | (40 %) | 8 | (25 %) |
| Some secondary | 5 | (15 %) | 2 | (8 %) | 7 | (12 %) | 18 | (67 %) | 0 | (0 %) | 18 | (56 %) |
| Completed secondary | 29 | (85 %) | 22 | (85 %) | 51 | (85 %) | 2 | (7 %) | 1 | (20 %) | 3 | (9 %) |
| More than secondary | 0 | (0 %) | 0 | (0 %) | 0 | (0 %) | 1 | (4 %) | 2 | (40 %) | 3 | (9 %) |
|
| 34 | 26 | 60 | 27 | 5 | 32 | ||||||
Fig. 3SMS experience by age and sex of participating health workers in Malawi (a) and Ghana (b)
Summary of unique cases reported by HSAs (Malawi) and CHWs (Ghana) by SMS
| Study area | No of hydrocoeles | No of lymphoedema | Total | ||||
|---|---|---|---|---|---|---|---|
| Mild | Moderate | Severe | Unknown | All | |||
|
| |||||||
| St Montfort/Mafale | 82 | 14 | 11 | 9 | 2 | 36 | 118 |
| Bereu | 47 | 15 | 1 | 1 | 1 | 18 | 65 |
| Kasinthula | 39 | 21 | 6 | 8 | 1 | 36 | 75 |
| Total | 168 | 50 | 18 | 18 | 4 | 90 | 256 |
|
| |||||||
| Ahanta West | 175 | 100 | 62 | 29 | 0 | 191 | 360 |
Age and sex distribution of reported lymphoedema cases by severity and study location
| Malawi | Ghana | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Lymphoedema severity | Reported Lymphoedema severity | ||||||||||||||||
| Mild | Moderate | Severe | Total | Mild | Moderate | Severe | Total | ||||||||||
|
|
| 12 | (24 %) | 7 | (39 %) | 7 | (39 %) | 29 | (32 %) | 28 | (28 %) | 18 | (29 %) | 8 | (28 %) | 54 | (28 %) |
|
| 38 | (76 %) | 11 | (61 %) | 11 | (61 %) | 61 | (68 %) | 72 | (72 %) | 44 | (71 %) | 21 | (72 %) | 137 | (72 %) | |
|
| |||||||||||||||||
|
| 1 | (2 %) | 1 | (6 %) | 0 | (0 %) | 2 | (2 %) | 7 | (7 %) | 1 | (2 %) | 0 | (0 %) | 8 | (4 %) | |
|
| 6 | (12 %) | 1 | (6 %) | 3 | (17 %) | 10 | (11 %) | 13 | (13 %) | 4 | (6 %) | 1 | (3 %) | 18 | (9 %) | |
|
| 8 | (16 %) | 2 | (11 %) | 1 | (6 %) | 11 | (12 %) | 21 | (21 %) | 14 | (23 %) | 6 | (21 %) | 41 | (21 %) | |
|
| 8 | (16 %) | 4 | (22 %) | 2 | (11 %) | 16 | (18 %) | 22 | (22 %) | 11 | (18 %) | 14 | (48 %) | 47 | (25 %) | |
|
| 15 | (30 %) | 4 | (22 %) | 3 | (17 %) | 22 | (24 %) | 24 | (24 %) | 13 | (21 %) | 6 | (21 %) | 43 | (23 %) | |
|
| 7 | (14 %) | 4 | (22 %) | 5 | (28 %) | 17 | (19 %) | 8 | (8 %) | 11 | (18 %) | 2 | (7 %) | 21 | (11 %) | |
|
| 5 | (10 %) | 2 | (11 %) | 4 | (22 %) | 12 | (13 %) | 5 | (5 %) | 8 | (13 %) | 0 | (0 %) | 13 | (7 %) | |
|
| 50 | 18 | 18 | 90 | 100 | 62 | 29 | 191 | |||||||||
Summary of verification data
| Identified Lymphoedema | Identified Hydroceole | ||||
|---|---|---|---|---|---|
| N | Lymphoedema PPV (95 % CI) | N | Hydrocoele PPV (95 % CI) | Hydrocoele + hernia PPV (95 % CI) | |
|
| |||||
| St Montfort/Mafale | 23 | 0.87 (0.653, 0.966) | 26 | 0.92 (0.734, 0.987) | 0.96 (0.784, 0.998) |
| Bereu | 8 | 0.88 (0.467, 0.993) | 15 | 0.93 (0.660, 0.997) | 1.00 (0,747, 1.00) |
| Kasinthula | 11 | 1.00 (0.679, 1.000) | 8 | 0.88 (0.467, 0.993) | 0.88 (0.467, 0.993) |
| Overall | 42 | 0.90 (0.765, 0.969) | 49 | 0.92 (0.795, 0.974) | 0.96 (0.849, 0.993) |
|
| |||||
| Ahanta West | 34 | 0.94 (0.789, 0.990) | 59 | 0.47 (0.351, 0.617) | 0.71 (0.571, 0.815) |
Assessment of the agreement in lymphoedema severity between the physician and the health worker
| Health worker assessment | ||||
|---|---|---|---|---|
| Mild | Moderate | Severe | ||
|
| ||||
|
|
| 12 | 4 | 0 |
|
| 1 | 6 | 4 | |
|
| 1 | 3 | 6 | |
|
| ||||
|
|
| 3 | 2 | 0 |
|
| 10 | 7 | 0 | |
|
| 1 | 3 | 4 | |
Comparison of lymphoedema data with MDA reports
| Lymphoedema | Estimated Adult Population | Reported | Adjusted by PPV | Adjusted by under-reporting estimate and PPV | Reported during MDAa |
|---|---|---|---|---|---|
|
| |||||
| St Montfort/Mafale | 35,588 | 36 | 31 | 37 | 3 |
| Bereu | 8,596 | 18 | 16 | 18 | 14 |
| Kasinthula | 6,690 | 36 | 36 | 42 | 13 |
| Total | 50,874 | 90 | 81 | 94 | 30 |
|
| |||||
| Selected communities in Ahanta West | 24,835 | 191 | 180 | N/A | 13 |
aMDA figures include children
Comparison of hydrocoele data with MDA reports
| Hydrocoele | Estimated Adult Population | Reported | Adjusted by PPV | Adjusted by under-reporting estimate and PPV | Reported during MDAa |
|---|---|---|---|---|---|
|
| |||||
| St Montfort/Mafale | 35,588 | 82 | 75 | 114 | 26 |
| Bereu | 8,596 | 47 | 44 | 66 | 31 |
| Kasinthula | 6,690 | 39 | 36 | 55 | 6 |
| Total | 50,874 | 168 | 155 | 234 | 63 |
|
| |||||
| Selected communities in Ahanta West | 24,835 | 175 | 82 | N/A | 12 |
aMDA figures include children
Feedback from health workers provided via post-study questionnaires and focus group discussions
| Feedback from health workers | |
|---|---|
| “The community [has] been very happy with the programme and enjoyed it. There is a great linkage between the HSA and the community.” |
|
| “The programme is very important because these patients will be assisted accordingly; it is encouraging [the] relationship between the HSA and the community” |
|
| “It is fast information, and it is easy to get good data in our catchment area.” |
|
| “It has helped health workers to meet hydrocoele and lymphoedema cases.” |
|
| “my relationship with the community has improved due to the study and feel happy that [I] could give management advice” |
|
| “I am happy that the burden of my community is now known” | Female CHW, Ghana aged 46-55 |
| “My community will profit from this method of surveillance” |
|